MonumenTAL-3
Phase 3 Clinical Trial Comparing the Efficacy of an Investigational Medication Combined with Daratumumab or Daratumumab and Pomalidomide Versus Daratumumab, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma.
Filters
Save & Share
Clear Filters
Location
Explore options near your patient - or anywhere in the US.
Diagnosis
Treatment History
BCMA Therapy
This stands for B Cell Maturation Antigen (BCMA) and includes treatments such as ide-cel, cilta-cel or belantamab mafodotin.
Near Add Your Location
Sorting 35 by
University of Arizona Cancer Center
Tucson, AZ
- Accepting patients
University of Arkansas for Medical Sciences (UAMS)
Little Rock, AR
- Accepting patients
- Accepting patients
- Accepting patients
University of Illinois at Chicago
Chicago, IL
- Accepting patients
Massachusetts General Hospital
Boston, MA
- Accepting patients
Boston Medical Center
Boston, MA
- Accepting patients
University of Massachusetts Medical School
Worcester, MA
- Accepting patients
- Accepting patients
University of Mississippi Medical Center
Jackson, MS
- Accepting patients
1,326 hidden based on your filters. Show All
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.